Ruben Rose

University Hospital Schleswig-Holstein

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (6)

Momsen Reincke

Charité - Universitätsmedizin Berlin

GERMANY

View details

Marcel Mueller

Group leader/ Prof. Dr. rer. nat.

Charité - Universitätsmedizin Berlin

GERMANY

View details

Victor M Corman

GERMANY

View details

Jakob Kreye

GERMANY

View details

Paula Hoff

GERMANY

View details

Jakob Trimpert

Freie Universität Berlin

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ruben Rose

Research Interests

Explore related searches

Contact this professor

Articles (11)

In vitro and in vivo effects of Pelargonium sidoides DC. root extract EPs® 7630 and selected constituents against SARS-CoV-2 B.1, Delta AY.4/AY.117 and Omicron BA.2

Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations

Limited antibody response after BA.4‐5 adapted booster vaccination in rheumatic patients receiving anti‐TNF therapy: Results of a case series

Humoral immune response after different SARS-CoV-2 vaccination regimens

The long term vaccine‐induced anti‐SARS‐CoV‐2 immune response is impaired in quantity and quality under TNFα blockade

Delta or Omicron BA.1/2‐neutralizing antibody levels and T‐cell reactivity after triple‐vaccination or infection

The pre-exposure SARS-CoV-2-specific T cell repertoire determines the quality of the immune response to vaccination

COVID-19 bei einer Großveranstaltung: Erfahrungen aus der Kieler Woche 2022

Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron

SARS-CoV-2 Rapid Antigen Test Sensitivity and Viral Load in Freshly Symptomatic Hospital Employees, December 2020 to February 2022

Antiviral susceptibility of recombinant Herpes simplex virus 1 strains with specific polymerase amino acid changes

Collaborators (6)

Momsen Reincke

Marcel Mueller

Victor M Corman

Jakob Kreye

Paula Hoff

Jakob Trimpert

Make your next move.